Literature DB >> 8303757

Delayed protection by MK-801 and tetrodotoxin in a rat organotypic hippocampal culture model of ischemia.

J J Vornov1, R C Tasker, J T Coyle.   

Abstract

BACKGROUND AND
PURPOSE: The hippocampus demonstrates a regional pattern of vulnerability to ischemic injury that depends on its characteristic differentiation and intrinsic connections. We now describe a model of ischemic injury using organotypic hippocampal culture, which preserves the anatomic differentiation of the hippocampus in long-term tissue culture.
METHODS: Ischemic conditions were modeled by metabolic inhibition. Cultures were briefly exposed to potassium cyanide to block oxidative phosphorylation and 2-deoxyglucose to block glycolysis. The fluorescent dye propidium iodide was used to observe membrane damage in living cultures during recovery.
RESULTS: 2-Deoxyglucose/potassium cyanide incubation resulted in dose-dependent, regionally selective neuronal injury in CA1 and the dentate hilus, which began slowly after 2 to 6 hours of recovery. Subsequent histological examination of cultures after 1 to 7 days of recovery demonstrated neuronal pyknosis that was correlated with the early, direct observation of membrane damage with propidium. Both propidium staining and histological degeneration were prevented by the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 when administered 30 minutes after the end of the exposure to 2-deoxyglucose and potassium cyanide. Tetrodotoxin, which blocks voltage-dependent sodium channels, had protective effects that were greatest during the period of 2-deoxyglucose and potassium cyanide incubation but also produced protection against the mildest conditions of metabolic inhibition when administered after 30 minutes of recovery.
CONCLUSIONS: This in vitro model reproduced elements of the time course, regional vulnerability, and pharmacologic sensitivities of in vivo ischemic hippocampal injury. Inhibition of metabolism in organotypic culture provides a rapid, easily controlled injury and reproduces the in vitro pattern of hippocampal regional vulnerability to ischemia. It is the first in vitro model of ischemia to exhibit complete protection by delayed administration of an NMDA receptor antagonist during recovery from a brief insult. The protective effects of tetrodotoxin suggest that an early period of sodium entry into cells during and after ATP depletion may be responsible for the more prolonged period of toxic NMDA receptor activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8303757     DOI: 10.1161/01.str.25.2.457

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Neuroprotection of cerebrolysin in tissue culture models of brain ischemia: post lesion application indicates a wide therapeutic window.

Authors:  E Schauer; R Wronski; J Patockova; H Moessler; E Doppler; B Hutter-Paier; M Windisch
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

2.  Calretinin-immunoreactivity in organotypic cultures of the rat cerebral cortex: effects of serum deprivation.

Authors:  D M Vogt Weisenhorn; E Weruaga-Prieto; M R Celio
Journal:  Exp Brain Res       Date:  1996-02       Impact factor: 1.972

3.  A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity.

Authors:  Vinogran Naidoo; Spyros P Nikas; David A Karanian; Jeannie Hwang; Jianhong Zhao; JodiAnne T Wood; Shakiru O Alapafuja; Subramanian K Vadivel; David Butler; Alexandros Makriyannis; Ben A Bahr
Journal:  J Mol Neurosci       Date:  2010-11-11       Impact factor: 3.444

4.  Gephyrin alterations due to protein accumulation stress are reduced by the lysosomal modulator Z-Phe-Ala-diazomethylketone.

Authors:  Sophia Ryzhikov; Ben A Bahr
Journal:  J Mol Neurosci       Date:  2007-09-18       Impact factor: 3.444

5.  Neurotoxic lipid peroxidation species formed by ischemic stroke increase injury.

Authors:  Stephanie L H Zeiger; Erik S Musiek; Giuseppe Zanoni; Giovanni Vidari; Jason D Morrow; Ginger J Milne; BethAnn McLaughlin
Journal:  Free Radic Biol Med       Date:  2009-08-19       Impact factor: 7.376

Review 6.  Organotypic Hippocampal Slices as Models for Stroke and Traumatic Brain Injury.

Authors:  Qian Li; Xiaoning Han; Jian Wang
Journal:  Mol Neurobiol       Date:  2015-07-30       Impact factor: 5.590

7.  Neuroprotective profile of lifarizine (RS-87476) in rat cerebrocortical neurones in culture.

Authors:  G R May; W S Rowand; J G McCormack; R D Sheridan
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemia.

Authors:  C M Brown; C Calder; C Linton; C Small; B A Kenny; M Spedding; L Patmore
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

Review 9.  Investigating the mechanisms underlying neuronal death in ischemia using in vitro oxygen-glucose deprivation: potential involvement of protein SUMOylation.

Authors:  Helena Cimarosti; Jeremy M Henley
Journal:  Neuroscientist       Date:  2008-12       Impact factor: 7.519

10.  Galanin acts as a neuroprotective factor to the hippocampus.

Authors:  Caroline R Elliott-Hunt; Barnaby Marsh; Andrea Bacon; Robert Pope; Penny Vanderplank; David Wynick
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.